Sionna Therapeutics, Inc.
SION
$39.46
$0.451.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.28M | -18.07M | -16.48M | -15.85M | -25.44M |
| Total Depreciation and Amortization | 189.00K | 147.00K | 159.00K | 167.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.96M | 2.16M | 1.89M | 764.00K | 9.16M |
| Change in Net Operating Assets | 1.90M | -2.40M | -1.85M | 3.14M | -1.57M |
| Cash from Operations | -15.23M | -18.15M | -16.29M | -11.78M | -17.69M |
| Capital Expenditure | -87.00K | 0.00 | -86.00K | -27.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.19M | -23.25M | -141.11M | 15.26M | 10.41M |
| Cash from Investing | 23.10M | -23.25M | -141.19M | 15.23M | 10.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.97M | -- | 202.39M | 25.00K | 73.00K |
| Repurchase of Common Stock | -- | -312.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1.43M | -1.07M |
| Cash from Financing | 1.97M | -312.00K | 202.39M | -1.41M | -996.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.85M | -41.71M | 44.91M | 2.04M | -8.28M |